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Background: In Brazil, 72% of all deaths in 2007 were attributable to non-communicable diseases (NCD). We used a
risk and related factor based index to prioritize NCD prevention programs in the combined 26 capital cities and the
federal district (i.e., Brasilia) of Brazil.
Methods: We used 2006–2011 data (adults) from census and Brazil's surveillance of 12 NCD risk factors and 74
disease group mortality. The risk and related factors were: smoking, physical inactivity, overweight-obesity, low fruits
and vegetables intake, binge drinking, insufficient Pap smear screening (women aged 25 to 59 years), insufficient
mammography screening (women aged 50 to 69 years), insufficient blood pressure screening, insufficient blood
glucose screening, diagnosis of hypercholesterolemia, diagnosis of hypertension and diagnosis of diabetes. We
generated six indicators: intervention reduction of the risk factor prevalence, intervention cost per person,
prevalence of risk factor, deaths attributable to risk factor, risk factor prevalence trend and ratio of risk factor
prevalence between people with and without a high school education. We transformed risk and related factor
indicators into priority scores to compute a priority health index (PHI). We implemented sensitivity analysis of PHI
by computing it with slightly altered formulas and altering values of indicators under the assumption of bias in
their estimation. We ranked risk factors based on PHI values.
Results: We found one intermediate (i.e., overweight-obesity) and six top risk and related factors priorities for NCD
prevention in Brazil's large urban areas: diagnosed hypertension, physical inactivity, blood pressure screening,
diagnosed hypercholesterolemia, smoking and binge drinking.
Conclusion: Brazil has already prioritized the six top priorities (i.e., hypertension, physical inactivity, blood pressure
screening, hypercholesterolemia, smoking and binge drinking) and one intermediate priority (i.e., overweight-obesity)
for NCD prevention identified in this report. Because effective interventions to reduce disease burden associated with
each of the six priority risk factors are available, strategies based on these interventions need to be sustained in order
to reduce NCD burden in Brazil. PHI can be used to track NCD prevention and health promotion actions at the local
and national level in Brazil and in countries with similar public health surveillance systems.* Correspondence: simoese@bellsouth.net
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In Brazil, 72% of all deaths in 2007 were attributable to
non-communicable diseases (NCDs) [1]. As Brazil’s popu-
lation continued to grow and age [2-4], the burden of
NCDs will increase at a time when the country is still
dealing with a threat of infectious diseases and poverty-
related health outcomes [4,5].
NCD prevention and health promotion policies and
strategies of Brazil, especially at city level, have been
strengthened after enactment in 1990 of the 1988 federal
health reform and the creation of Brazil’s Universal
Health Care System (SUS) that covers the Brazilians for
free [6]. This decentralized system is directly run by each
municipality and funded by a national health fund.
As of 2010, approximately 86% of Brazil’s populations
lived in an urban center (i.e., city and vicinity) with
about 32% living in 16 major metropolitan regions and
42% living in 26 state capital cities and the city of
Brasilia (i.e., federal district of Brazil) [7]. This level of
urbanization and associated lifestyle changes (e.g., com-
pressed leisure time, smoking, poor diet, increased alco-
hol consumption) contributes to increases in NCD and
poor population health in Brazil [8,9].
Because funds are limited, public health programs need
to be prioritized [10,11]. Hence, we used the priority health
index (PHI), a prioritization methodology applied in the
State of Missouri in the United States since 2000 [12,13]
and Italy [14] to prioritize public health programs for
NCD in the combined 26 state capital cities and the city of
Brasilia. More specifically, our study objectives were to: 1)
use Brazil’s public health surveillance data to generate
NCD focused PHI; 2) use PHI to identify NCD priorities
for 27 capital cities in Brazil; and 3) compare the PHI iden-
tified priorities with prevention priorities in Brazil.
Methods
PHI utilizes readily available public health surveillance
data to prioritize health issues by balancing the relative
impact of indicators across six criteria of prioritization.
We used all available data from 2000 to 2011 from the
Brazil's Surveillance System on Risk and Related Factors
(hereafter referred to as factor) for Non-transmissible
Disease through Telephone Interviews (VIGITEL) [15,16],
Information System for Mortality (SIM) [17], and census
data [18] in all 27 cities. VIGITEL, launched in 2006,
provided continuous surveillance data based on about
54,000 completed interviews with adults per year (around
2,000 per state capital) [15]. SIM captures all causes of
death, location of death, residency location and socio-
demographics of the deceased individuals [17]. We
focused on 12 NCD factors and 74 groups of diseases and
health conditions to calculate PHI.
The 12 NCD factors defined by VIGITEL were
(Appendix 1): being a current smoker (smoking); beingsedentary or reaching insufficient levels of physical activ-
ity (physical inactivity); having a body mass index (BMI)
greater than 25 (overweight- obesity); consuming fruits
and vegetables fewer than five times in a week (low
fruits and vegetables intake); consuming more than five
standard alcoholic drinks on a single occasion for men
(four doses for women) (binge drinking); women (25–59
years) who have not had a Pap test in the last three years
(insufficient Pap smear screening); women (50–69 years)
who have not had a mammography in the last two years
(insufficient mammography screening); having not had a
blood pressure measured in the last one year (insuffi-
cient BP screening); having not had a blood glucose
measured in the last two years (insufficient glucose
screening); having been diagnosed with hypercholester-
olemia (hypercholesterolemia); having been diagnosed
with hypertension (hypertension); and having been diag-
nosed with diabetes (diabetes) [15].
We generated six indicators within the criteria: inter-
vention effectiveness (relative reduction in the preva-
lence of a risk factor); intervention cost (cost per person
reached by an effective intervention), magnitude (preva-
lence of the risk factors); severity (deaths attributable to
the risk factors); urgency (risk factor prevalence trend
over time); disparity (ratio of risk factor prevalence be-
tween low to high education attainment). PHI modulates
the population health burden measured by the number
of deaths attributable to a factor with the inclusion of
other priority criteria: magnitude and urgency of the risk
factor and its presented socioeconomic disparity; the
cost and effectiveness of an intervention to reduce the
risk factor magnitude and disparity, and stem its rate of
increase [14].
We used the 2011 prevalence of a factor, relative risks
for the relationship between risk factors, and mortality
by age-sex specific groups to calculate the mortality
attributable to each risk factor. The underlying causes of
deaths by ICD 9 and ICD 10 for the 75 diseases or
conditions by specific age-sex groups are presented in
Appendix 2. We used relative risks previously published
[19]. We then generated age and gender specific popula-
tion attributable fractions (PAF) (Appendix with spread-
sheet of calculations is available upon request). We used
the following formula: PAF = (P0 + P1RR1 + P2RR2 +… +
PKRRK) -1/(P0 + P1RR1 + P2RR2 +… + PKRRK) to adjust
for levels of risk factors [20]. These risk factors were:
cigarette smoking (never smokers, former smokers,
current smokers); alcohol consumption (males: ab-
stainers, 0–39 g, 40–59 g, 60+ g, and binge; females: ab-
stainers, 0–19 g, 20–39 g, 40+ g and binge); and physical
inactivity (highly active, active, insufficient, inactive). All
other nine risk factors were dichotomous (yes/no). We
used the following formula to estimate PAF for dichot-
omous variables: PAF = P(RR-1)/1+ (RR-1) [21]. We then
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attributable deaths (severity criterion).
The urgency criterion is delta (Δ), the coefficient of lin-
ear trend of the prevalence of the risk factor between 2006
and 2011. We estimated Δ by the slope coefficient (i.e., β1)
of the regression line for the period of time: Y = β0 + β1 X;
where Y = the prevalence of the risk factor and X = time in
year. We set the Δ value to zero to indicate no trend if the re-
gression coefficient is not statistically significant (using two-
sided test with p-values ≤0.05). Hence, if the prevalence is
increasing over time, it indicates that this risk factor is more
urgent than that of another risk factor for which the preva-
lence is decreasing or stable. Because diabetes and blood
pressure screening were only available for 2010 and 2011
through VIGITEL, we estimated their delta using the follow-
ing formula: Δ = (Pf / Pb -1)/n-1; where n is the number of
years, Pf and Pb are the prevalence in the last and preceding
years, respectively.
We defined socio-economic disparity in health as the
2011 risk factor prevalence ratio between persons with
fewer than 12 years of education and 12 or more years of
education. We used the value of the ratio when statisti-
cally significant (using two-sided test with p-values ≤0.05)
or greater than 10%; otherwise, a value of 1 was assigned.
We used intervention effectiveness and cost measures
from a review of the English literature between 1990 and
2009 m. Intervention cost and effectiveness measures for
the prevention of chronic diseases were unavailable in
the Portuguese literature. We used the following formula
to estimate effectiveness: Effect = P final – P baseline,
where P final is the prevalence at the end of the interven-
tion follow-up period and P baseline is the prevalence at
the beginning of the follow-up period. We used the per
capita cost of a public health intervention for the duration
of the intervention study to estimate the cost criterion.
Because cost and effectiveness data were unavailable for
diabetes screening, we used the available cost and effect-
iveness measures for cholesterol screening as proxy.
The magnitude of the risk factors was estimated by
the prevalence of the risk factor in 2011.
We standardized all our risk factor indicators to gener-
ate dimensionless and comparable scores. We re-scaled
our standardized scores to avoid negative values. We
used the following formula to transform the indicator
into a re–scaled and standardized score: S = 3 + ( I – Avg
(I) )/Sd (I), where S is the score of the indicator (I), 3 is
a re-scale constant, I is the indicator (e.g., linear coeffi-
cient on risk factor prevalence between 2006 and 2011),
Avg (I) is the mean of the indicator I across all risk
factors, and Sd (I) is the standard deviation of the indi-
cator I across all risk factors. We divided the cost value
by 1000 before standardizing and re-scaling it in order
to keep all indicators with identical orientation in the
PHI formula (i.e., higher values equal higher priorityranking). We generated three PHI as a sensitivity ana-
lysis. We created three PHI: the sum of the priority
ranked values of indicators (A), product of the scores
(B), and sum of scores (C) across the seven criteria. We
created one composite PHI measure: the weighted aver-
age of the ranking values of a risk factor for indexes A,
B and C (Composite D). We ranked the risk factors
based on the PHI values.
Ethical considerations
The data collection done by the VIGITEL and SIM were
approved by the National Human Research Ethics Com-
mittee of the Brazilian Ministry of Health.
Results
The original indicators and the score values are presented
in Tables 1 and 2. The highest disparity scores were insuf-
ficient Pap smear and mammography screening, followed
by diabetes. Overweight-obesity and diabetes presented
the highest urgency due to recent increasing trends in
prevalence, while overweight-obesity and low fruits/vege-
tables intake had the highest magnitude. The factors asso-
ciated with the highest mortality burden per the severity
score were hypertension, heavy alcohol consumption and
smoking, followed by physical inactivity and insufficient
BP screening. Hypercholesterolemia, diabetes, hyperten-
sion, physical inactivity, and BP screening had the highest
scores for intervention effectiveness. Binge drinking, phys-
ical inactivity, smoking, hypertension, hypercholesterol-
emia and BP screening had the lowest cost score.
The priority health indices (A, B and C), and the com-
posite priority index (D) are presented in Table 3. Hyper-
tension, physical inactivity, and blood pressure screening
were ranked at the top across priority indices A, B and C
and composite index D.
Hypertension, physical inactivity, blood pressure screen-
ing, diagnosed hypercholesterolemia, smoking and binge
drinking were the top five ranked factors on the composite
D index. Overweight-obesity had intermediate priority and
all other factors had much lower priority. Overweight-
obesity, hypertension, low fruits and vegetables intake,
smoking and insufficient Pap smear were the top five
priorities based on a composite score of the three PHI that
had cost and effectiveness excluded from their calculations
(data not shown in tables).
Discussion
To our knowledge, this is the first study to present a
prioritization model for health intervention for Brazil
urban areas and the majority of population. Our results
show that hypertension, physical inactivity, blood pres-
sure screening, diagnosed hypercholesterolemia, smok-
ing and binge drinking are the leading burdens and have
the most impact on health. It also shows overweight-
Table 1 Risk factor priority indicator values: combined 27 capital cities total
Risk factor Cost1 Cost transformed2 Effectiveness3 Severity4 Magnitude5 Urgency6 Disparity7
Current smoking 4.90 204.082 0.116 21298.000 0.150 −0.310 1.520
Physical inactivity 4.30 232.558 0.350 17505.000 0.150 0.000 0.890
Overweight-obesity 41.70 23.981 0.095 2453.000 0.480 1.390 1.000
Eating < 5 servings of fruit and vegetables per week 10.00 100.000 0.032 904.000 0.700 0.000 1.290
Abusive Alcohol Intake (binge drinking) 4.00 250.000 0.080 22927.000 0.190 0.000 0.810
Had no Papanicolaou in last three years 11.40 87.719 0.180 66.000 0.190 0.000 2.060
Had no Mammography in last two years 550.00 1.818 0.182 79.000 0.270 −0.560 2.410
Had no BP Screening in last one year 10.00 100.000 0.317 9816.000 0.210 0.000 1.600
Had no Glucose Screening in last two years 41.70 23.981 0.076 414.000 0.110 0.000 1.470
Has been diagnosed with high cholesterol 10.00 100.000 0.470 5518.000 0.170 0.000 1.000
Has been diagnosed with hypertension 10.00 100.000 0.225 25402.000 0.230 0.000 1.360
Has been diagnosed with diabetes 10.00 100.000 0.235 1071.000 0.060 0.170 1.620
Mean - 110.345 0.197 8954.417 0.243 0.058 1.419
Standard deviation - 80.323 0.131 10016.920 0.177 0.460 0.477
1Intervention Cost (US$) per Person Covered.
2Transformation of Intervention Cost per Person Covered (i.e., 1000/intervention cost).
3Percent reduction in the prevalence of Risk Factor due to Intervention.
4Mortality Attributable to Risk Factor.
5Prevalence of Risk Factor.
6Unit of change in Risk Factor prevalence per year (Slope).
7Low (<12 years) to High (= > 12 years) Education Ratio of the Risk Factor Prevalence.
Table 2 Two Risk factor priority indicator scores&,! for the combined 27 cities total
Cost1 Effectiveness2 Severity3 Magnitude4 Urgency5 Disparity6
Risk factor Score1 Score2 Score1 Score2 Score1 Score2 Score1 Score2 Score1 Score2 Score1 Score2
Current smoking 4.167 3 2.384 8 4.232 3 2.479 9 2.202 11 3.211 5
Physical inactivity 4.522 2 4.175 2 3.854 4 2.479 9 2.875 3 1.890 11
Overweight-obesity 1.925 10 2.223 9 2.351 7 4.338 2 5.895 1 2.121 9
Eating < 5 servings of fruit and
vegetables per week
2.871 4 1.740 12 2.196 9 5.578 1 2.875 3 2.729 8
Abusive alcohol intake (binge drinking) 4.739 1 2.108 10 4.395 2 2.704 6 2.875 3 1.722 12
Had no papanicolaou in last three years 2.718 9 2.874 7 2.113 12 2.704 6 2.875 3 4.344 2
Had no mammography in last two years 1.649 12 2.889 6 2.114 11 3.155 3 1.659 12 5.078 1
Had no BP screening in last one year 2.871 4 3.923 3 3.086 5 2.817 5 2.875 3 3.379 4
Had no Glucose Screening in last two
years
1.925 10 2.077 11 2.147 10 2.253 11 2.875 3 3.107 6
Has been diagnosed with high
cholesterol
2.871 4 5.094 1 2.657 6 2.591 8 2.875 3 2.121 9
Has been diagnosed with hypertension 2.871 4 3.218 5 4.642 1 2.930 4 2.875 3 2.876 7
Has been diagnosed with diabetes 2.871 4 3.295 4 2.213 8 1.972 12 3.244 2 3.421 3
&Score1 is created by re-scaling and standardizing the risk factor indicator.
!Score2 is the ranking value of the risk factor indicator.
1Intervention Cost (US$) per Person Covered.
2Transformation of Intervention Cost per Person Covered (i.e., 1000/intervention cost).
3Percent reduction in the prevalence of Risk Factor due to Intervention.
4Mortality Attributable to Risk Factor.
5Prevalence of Risk Factor.
6Unit of change in Risk Factor prevalence per year (Slope).
7Low (<12 years) to High (= > 12 years) Education Ratio of the Risk Factor Prevalence.
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Table 3 Risk factor ranking by priority health indexes (with risk factors ordered from top to lowest based on the
composite priority index D)
















Has been diagnosed with
hypertension
24 1 1039.002 1 19.41199 2 1.33 1
Physical Inactivity 31 3 980.0549 2 19.79463 1 2.00 2
Had no BP screening in
last one year
24 1 951.235 3 18.95115 3 2.33 3
Has been diagnosed with
high cholesterol
31 3 614.1151 5 18.20992 7 5.00 4
Current smoking 39 9 736.7486 4 18.67477 5 6.00 5
Abusive alcohol intake
(binge drinking)
34 6 587.8737 6 18.54317 6 6.00 5
Overweight-Obesity 38 8 545.5287 8 18.85233 4 6.67 7
Eating < 5 servings of fruit
and vegetables per week
37 7 480.3386 9 17.99008 8 8.00 8
Had no papanicolaou in
last three years
39 9 557.361 7 17.62787 9 8.33 9
Has been diagnosed
with diabetes
33 5 458.1501 10 17.01621 10 8.33 10
Had no mammography in
last two years
45 11 267.5791 11 16.54336 11 11.00 11
Had no glucose screening
in last two years
51 12 172.8065 12 14.38453 12 12.00 12
aSum of the ranking values of the risk factor indicators.
bProduct of re-scaled and standardized risk factor Indicators.
cSum of re-scaled and standardized risk factor indicators.
dComposite Index consisting of the average of the rankings of priority indexes a, b and c.
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Brazil. Indeed, our findings present a road map for de-
veloping and implementing prevention programs or for
accelerating existing ones. These programs are crucial
for a country with a free health system, and a growing
and aging population.
The World Health Organization (WHO) included five
of these factors among the top seven priorities for
middle-income countries and top five priorities for high-
income countries [22]. Moreover, the Brazilian Ministry
of Health (MH) National Policy of Health Promotion,
launched in 2006, targeted directly physical inactivity,
smoking and excessive alcohol intake, while indirectly
targeting overweight-obesity and hypercholesterolemia
through “poor diet” among its five targets for health pro-
moting strategies [23]. More recently, physical inactivity,
smoking and overweight-obesity have been targeted with
specific actions through the 2011–2022 Strategic Plan-
ning for Tackling NCD in Brazil [24].
Our findings of an increasing prevalence of overweight
and obesity in urban areas have been previously re-
ported. One research reported an increase in adult obes-
ity from 10.8% to 13.5% between 2006 and 2009 [25].
Another reported a higher rate of obesity increase from
1989 and 2009 among poor individuals compared tonon-poor [26]. Indeed, this means that large societal
changes led to an imbalance between caloric intake and
expenditure in the country. As a result, the country has
launched a nationwide program to increase physical
activity and improve diet, the Academias da Saude (i.e.,
Health Academies) [24]. This rise in obesity and over-
weight deserved further attention and proper manage-
ment through prevention in Brazil. High obesity levels
for long periods of time will make it a norm for the
population and there will be fewer incentives for individ-
uals to take action if obesity becomes acceptable.
MH goal is to expand Academias da Saude to 4,000
municipalities by 2011 [24]. Brazil’s promotion of phys-
ical activity started six years before Academias da Saude
(2005) through MH annual funding to the 27 capital cit-
ies for local interventions to promote physical activity
and health [27]. By 2010, this physical activity network
already included 469 projects. This shows the commit-
ment of MH and local health authorities to deal with the
health priorities and receptivity by communities. There-
fore, this effort should be supported as a means to share
experience, and lessons should be adopted to ensure that
success stories are copied.
Diagnosed hypertension, blood pressure screening and
diagnosed hypercholesterolemia were among the top
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cardiovascular morbidity and death are significant public
health issues in Brazil. Though cardiovascular disease
standardized mortality rates decreased in Brazil in the past
two decades, an increase in cardiovascular deaths is ex-
pected in the next decades [28]. Since 2011, hypertension-
related complications and deaths have been directly
targeted with preventive actions by MH. In February,
2011, MH initiated an unprecedented strategy of offering
free medication to control and reduce the burden of
hypertension, diabetes and asthma: the Saude nao tem
Preco program (i.e., Health is Priceless) program [29]. The
Saude nao tem Preco distributes, free of charge, 11
medicines–six for hypertension and five for diabetes–to
control blood pressure and diabetes. As of February, 2014,
the program, active in 4,119 cities through a network of
30,136 pharmacies, has provided services to 6.6 million
diabetic and 16.4 million hypertensive patients [30]. This
program will no doubt reduce the burden of blood pres-
sure and diabetes as long as patients are properly followed
to ensure the medication is controlling their conditions.
However, changes in health behaviors and proper clinical
management of hypercholesterolemia as in the use of
statins should also be promoted and such advices regularly
given [31].
We found about 84% of deaths were attributable to
hypertension, physical inactivity, smoking, overweight-
obesity, and binge drinking in our study. Our report of
the large death burden attributed to preventable factors
such as smoking and alcohol have been reported previ-
ously [32,33]. In 2003, researchers estimated that 24,222
out of 177,543 total deaths in Brazil were attributable to
smoking [32]. This figure is slightly higher than ours that
includes only capitals. Indeed, this is also due to the de-
clining smoking rates in the country. A 46% reduction of
smoking rates between 1989 and 2010 is due to national
policies, including taxation (1990), banning of advertising
(1996), warning on packages, and smoke-free laws [34].
The government of Brazil signed, ratified and enforced the
Framework Convention on Tobacco Control (FCTC) in
2003, 2005 and 2006, respectively [24]. The FCTC has
really made an impact on tobacco smoking and a reduc-
tion has been seen since its implementation.
Our estimated alcohol attributable deaths are lower
than previously reported in 2006 (22,927deaths com-
pared to 23,608 deaths) [33]. Differences in estimation
methodology, geography (i.e., only capitals), and year
prevalence of alcohol intake and deaths calculated could
explain this difference. Alcohol consumption is high in
Brazil with men consuming nearly 20 liters of pure alco-
hol while women consumed 8.9 liters in 2010 [35]. In
our study, binge drinking ranked high because of the ex-
cessive number of deaths attributed to alcohol, mainly
due to traffic accidents, other accidents and violence.Indeed, traffic accidents are responsible for more than
150,000 injuries every year with 35,000 fatal outcomes,
and an estimated cost of USD $14 billion per year [36].
However, recent policies have the potential to reduce
the alcohol burden in Brazil. In a recent report by
WHO, Brazil had implemented 10 out of 12 policies
known to reduce excessive intake of alcohol [35]. In
2008, Brazil introduced a policy consisting of near zero
tolerance on alcohol intake (legal BAC limit at 0.02 g/l)
while driving [37]. Initial reports have shown a decline
in alcohol burden manifested by reduction in hospital
admissions, health care costs and deaths related to traf-
fic accidents [38,39].
We found the highest health disparity based on educa-
tion for insufficient Pap smear and mammography
screening in our study. An estimated 52,680 new cases
of female breast cancer and 17,540 new cases of cervical
cancer were reported in 2012 [40]. Moreover, a recent
review of breast cancer in Brazil revealed low awareness
of breast cancer danger and low screening levels [41].
Indeed, early detection should be a priority for the coun-
try to avoid complications and increase the chance of a
cure. Several studies in Brazil reported large disparities
in Pap smear and mammography screening by educa-
tion, race, and other socio-economic factors [42,43].
Therefore, examining the reasons for disparities will help
in finding solutions to address the low screening in cer-
tain segments of the population. Moreover, it would
allow the MH to target programs to those in need and
maximize the utilization of available resources.
We found a significant and positive trend of diabetes
in Brazil. Previous studies reported increases in the
prevalence, hospitalization and deaths due to diabetes
[1]. Another study estimated that the prevalence of dia-
betes increased by 20% from 2006 to 2010 [44]. Diabetes
causes 278,778 years of potential life lost for every
100,000 people in Brazil, with an annual direct cost of
USD $3.952 billion in 2000, and an estimated annual in-
direct cost of USD $18.6 billion [44]. The introduction
of new guidelines for diabetes prevention, screening,
diagnosis, initial evaluation, and basic treatment in 2006
by MH has improved the management of diabetes [45].
Moreover, medication has been freely available since
1971 through the public health services and at 10% of its
market price through the Farmacia Popular (i.e., Popular
Pharmacy) program since 2006 [46]. In 2011, the Saude
nao tem Preco made metformin, glibenclamide, Human
insulin, and NPH insulin freely available for all through
the Farmacia Popular [47]. Indeed, the impact of these
programs will unfold in the coming years as there is a
lag between a program and outcome. However, these
programs will reduce the burden of diabetes as long as
patients are being monitored and make the necessary
behavioral changes.
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tions to reduce their prevalence between 8% and 35% with
per capita costs between $10 and $42 per person reached
[14]. A recent study estimated that 5% reduction in the
mean BMI in Brazil could reduce obesity and prevent 2.1
million prevalent cases of hypertension by 2050 [48].
Our study has some limitations. Risk and related factors
for infectious and other diseases in Brazil are not available.
Though the study focused on the combined data of 27
capital cities to generate the health priorities for urban
Brazil, priorities for each of the nearly 4000 municipalities
in Brazil including rural areas may be very different.
A major limitation of the PHI methodology is its de-
pendence on the quality of the surveillance data as in
the VIGITEL and SIM. VIGITEL’s main limitations are
the differential telephone coverage and survey nonre-
sponse that may result in significant differences of the
studied variables between individuals with and without a
telephone line, and respondents and non-respondents
[49,50]. But, a recent study reported that 15 out of 18 in-
dicators of VIGITEL were reproducible and valid [51].
Furthermore, the VIGITEL questionnaire only allows for
creation of a weekly frequency of consumption of fruits
and vegetables, while the recommended measure based
on risk of chronic diseases is five times a day [52].
Nevertheless, our categorization was sufficient to differen-
tiate cities as high, mid-high, middle and low consumption
of fruits and vegetables (data not shown in tables). SIM’s
main limitation is the completeness of death registration
as expressed by the reporting of high numbers of deaths
with undetermined causes, mainly in the North-east of
Brazil [53]. However, recent studies show improvement in
death reporting with 80% of municipalities providing valid
statistics [54]. In addition, the weights used to generate
factors prevalence estimates may render population attrib-
utable risk estimates biased compared to other methods
[55,56]. Yet, PHI remained stable (i.e., its values did not
change more than 10%) after simulations with 10% change
in the value of one or more health indicators. Finally, the
estimate of the number of attributable deaths used in PHI
may be biased [57].
A major strength of PHI is the ability to incorporate
other criteria and indicators. For example, the state of
Missouri interactive PHI (Priorities MICA) available in
the internet since 2002, adds other indicators (e.g., DALY),
and its dashboard allows users to incorporate a criterion
of community support for a public health issue [12,13].
PHI normalizes and harmonizes hundreds of statistical
calculations from multiple factors and diseases indicators
simultaneously, thus facilitating the prioritization process.
PHI may allow prioritization for population groups de-
fined by region, age, race/ethnicity, or sex group as well as
identify specific indicator, disease or factor weighing on
the ranking of the index.Conclusions
The top six priority factors for NCD in Brazil are hyper-
tension, physical inactivity, blood pressure screening,
hypercholesterolemia, smoking and binge drinking.
While, as of 2011, these six factors have been addressed
in Brazil with health promotion and prevention strat-
egies, more resources and effective strategies are needed
to address these factors and sustain gains. We provide a
model for the MH in Brazil to set priorities for interven-
tion programs. We believe this model is of great value
and could be used to monitor progress and evaluate
interventions in Brazil and countries with similar sur-
veillance systems. Moreover, the PHI model is simple to
implement but sophisticated in analyses, and it allows
for health officials to apply it in their own settings (e.g.,
locally or nationally).
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